Kevin Schulman Headshot
Report a problem with this profile
[email protected]

Kevin Schulman    

Professor Of Medicine at the Clinical Excellence Research Center at Stanford University

Dr. Kevin Schulman serves as Professor of Medicine, Associate Chair of Business Development and Strategy in the Department of Medicine, Director of Industry Partnerships and Education for the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He is the Director of Stanford's master degree program, the Master of Science in Clinical Informatics Management.

Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics. With over 500 publications, Dr. Schulman has had a broad impact on health policy (h-index = 80). His peer-reviewed articles have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is a member of the editorial/advisory boards of the American Heart Journal, Editor in Chief of Health Policy, Management and Innovation, and Senior Associate Editor of Health Services Research.

Prior to coming to Stanford, Dr. Schulman served as a Professor of Medicine at Duke University, directed the Health Sector Management Program at Duke’s Fuqua School of Business for a dozen years, created and directed the Duke University Master’s of Management in Clinical Informatics Program, and served as a Visiting Professor and Visiting Scholar at Harvard Business School.

He is a co-founder of Bivarus (exit January, 2018), co-founder and Managing Member of Faculty Connection, LLC., and is a Board Member of Grid Therapeutics.

He is an elected member of ASCI and AAP.

He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program.

Speech Topics

Preparing Healthcare for AI

We are living in a world of amazing technology innovation, but healthcare is struggling to understand and adopt these solutions in a meaningful way. Why is this so hard?

The innovation literature focuses on the relationship between technology innovation and business model innovation. Healthcare looks at technology but seems to assume that the business model will remain intact. Technology can only drive us to performance improvement (cost, quality, or access) when we are ready to ask hard questions about our business models.

We've been looking at this dilemma and have developed pathways to get beyond the status quo. With careful work, we can describe the economic opportunity and then build solutions that can attract resources and can scale.

Innovation in the health sector needs a combined effort at the firm level and the market level for us to achieve a new performance trajectory.

Health Policy in the US

It's an election year, and health care will be on the agenda. There are significant challenges in cost, quality, and access, but it is hard to understand just where we stand today and why addressing these challenges has been so daunting.

This talk will address the critical challenges for policymakers and the American Public:

  • Medicare and entitlement program funding
  • Provider consolidation and the provider workforce
  • Administrative costs in healthcare

The talk is designed to help level-set the economics underlying each of these issues. The talk can focus on the perspective of any segment of the market.

Related Speakers View all

More like Kevin